Cargando…
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648386/ https://www.ncbi.nlm.nih.gov/pubmed/36178036 http://dx.doi.org/10.1002/cac2.12365 |
_version_ | 1784827575525179392 |
---|---|
author | Fraunhoffer, Nicolas Alejandro Abuelafia, Analía Meilerman Chanez, Brice Bigonnet, Martin Gayet, Odile Roques, Julie Chuluyan, Eduardo Dusetti, Nelson Iovanna, Juan |
author_facet | Fraunhoffer, Nicolas Alejandro Abuelafia, Analía Meilerman Chanez, Brice Bigonnet, Martin Gayet, Odile Roques, Julie Chuluyan, Eduardo Dusetti, Nelson Iovanna, Juan |
author_sort | Fraunhoffer, Nicolas Alejandro |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9648386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96483862022-11-14 Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity Fraunhoffer, Nicolas Alejandro Abuelafia, Analía Meilerman Chanez, Brice Bigonnet, Martin Gayet, Odile Roques, Julie Chuluyan, Eduardo Dusetti, Nelson Iovanna, Juan Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-09-30 /pmc/articles/PMC9648386/ /pubmed/36178036 http://dx.doi.org/10.1002/cac2.12365 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Letters to the Editor Fraunhoffer, Nicolas Alejandro Abuelafia, Analía Meilerman Chanez, Brice Bigonnet, Martin Gayet, Odile Roques, Julie Chuluyan, Eduardo Dusetti, Nelson Iovanna, Juan Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity |
title | Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity |
title_full | Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity |
title_fullStr | Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity |
title_full_unstemmed | Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity |
title_short | Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity |
title_sort | inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648386/ https://www.ncbi.nlm.nih.gov/pubmed/36178036 http://dx.doi.org/10.1002/cac2.12365 |
work_keys_str_mv | AT fraunhoffernicolasalejandro inhibitionofglucuronidationinpancreaticcancerimprovesgemcitabineanticanceractivity AT abuelafiaanaliameilerman inhibitionofglucuronidationinpancreaticcancerimprovesgemcitabineanticanceractivity AT chanezbrice inhibitionofglucuronidationinpancreaticcancerimprovesgemcitabineanticanceractivity AT bigonnetmartin inhibitionofglucuronidationinpancreaticcancerimprovesgemcitabineanticanceractivity AT gayetodile inhibitionofglucuronidationinpancreaticcancerimprovesgemcitabineanticanceractivity AT roquesjulie inhibitionofglucuronidationinpancreaticcancerimprovesgemcitabineanticanceractivity AT chuluyaneduardo inhibitionofglucuronidationinpancreaticcancerimprovesgemcitabineanticanceractivity AT dusettinelson inhibitionofglucuronidationinpancreaticcancerimprovesgemcitabineanticanceractivity AT iovannajuan inhibitionofglucuronidationinpancreaticcancerimprovesgemcitabineanticanceractivity |